Fate Therapeutics Inc (FATE)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$0.9302

Buy

$0.9459

arrow-down$-0.02235 (-2.33%)

Prices updated at 15 May 2025, 14:47 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.
NASDAQ
arrow-down-0.7%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Biotechnology
Chairman
Dr. John D. Mendlein, J.D.,PhD
CEO
Dr. Bahram Valamehr, M.B.A.,PhD
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
181
Head office
12278 Scripps Summit Drive
San Diego
United States
92131
mobile
+1 858 875-1800
letter
info@fatetherapeutics.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Dr. William H. Rastetter,PhD
Chairman of the Board
0.08m
Dr. Robert S. Epstein, M.D.,M.S.
Independent Director
0.06m
Mr. Timothy P. Coughlin
Independent Director
0.06m
Dr. John D. Mendlein, J.D.,PhD
Vice Chairman of the Board
0.05m
Ms. Cindy R. Tahl, J.D.
Chief Legal and Compliance Officer and Corporate Secretary
0.50m
Mr. Matthew C. Abernethy
Independent Director
-
Dr. Shefali Agarwal, M.D.,M.P.H.
Independent Director
0.06m
Mr. Michael Lee
Independent Director
0.05m
Dr. Bahram Valamehr, M.B.A.,PhD
Director, President, Chief Executive Officer, Principal Financial Officer and Principal Accounting Officer
0.53m
Dr. Karin Jooss, PhD
Independent Director
0.06m
Dr. Yuan Xu, PhD
Independent Director
0.05m
Dr. Neelufar Mozaffarian, F.A.C.R.,M.D.,PhD
Independent Director
0.02m

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Redmile Group, LLC12,872,946
BlackRock Inc10,941,582
BlackRock, Inc.10,473,250
Vanguard Group Inc10,310,453
Boxer Capital LLC6,171,000

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
29 Jul 2024-
29 Jul 2024-
29 Jul 2024-
07 Jun 2024-
07 Jun 2024-
07 Jun 2024-
07 Jun 2024-
07 Jun 2024-
07 Jun 2024-
07 Jun 2024-
04 Mar 2024-
01 Feb 2024-
01 Feb 2024-
01 Feb 2024-
01 Feb 2024-
29 Jan 2024-
09 Jan 2024-
09 Jan 2024-
09 Jan 2024-
09 Jan 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.